STOCK TITAN

Medifast: Steamboat and Kiai each report an 8.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Steamboat Capital Partners, LLC and its Managing Member, Parsa Kiai, each reported beneficial ownership of 963,286 Medifast, Inc. (MED) shares, or 8.6%. The shares are owned by clients of the investment adviser, including investment funds of which an affiliate is general partner. Both reporting persons reported sole power to vote and dispose of the shares.

Clients bought shares in open-market transactions through brokers: 6,480 on October 28, 661 on November 6, 10,436 on November 18, and 100,000 on November 19, 2026. The November 19 purchase was at a weighted average price of $12.0464 per share, within a stated range of $11.855 to $12.15. The reported aggregate purchase price was approximately $10,463,681, excluding commissions. Medifast had 11,182,597 shares outstanding as of October 19, 2026.

Filing Explained

This Schedule 13D amendment reports Steamboat Capital and Parsa Kiai’s 8.6% beneficial stake and sole voting and disposition power; Schedule 13D is used for ownership disclosures when a holder may seek to influence control.

Beneficial ownership 963,286 shares each Reported by Steamboat Capital Partners, LLC and Parsa Kiai; shares owned by clients of the adviser.
Ownership percentage 8.6% each Percentage of the class reported for each reporting person.
Shares outstanding 11,182,597 shares As of October 19, 2026.
Aggregate purchase price Approximately $10,463,681 Excluding commissions; for shares acquired by clients.
November 19 purchase 100,000 shares Client open-market purchase on November 19, 2026.
Weighted average price $12.0464 per share November 19, 2026 purchase; stated price range was $11.855 to $12.15 per share.
beneficial owner regulatory
"may be deemed to be the beneficial owner"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole dispositive power regulatory
"Sole Dispositive Power 963,286.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
weighted average price financial
"the price reported in that row's column Price Per Share ($) is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MED shares did Steamboat Capital Partners and Parsa Kiai report owning?

Steamboat Capital Partners, LLC and Managing Member Parsa Kiai each reported beneficial ownership of 963,286 shares, or 8.6%. Clients of the adviser own the shares and have the right to receive dividends or sale proceeds.

What was the latest reported MED share purchase and price?

Clients of Steamboat Capital Partners, LLC reported an open-market purchase of 100,000 shares on November 19, 2026, at a weighted average price of $12.0464 per share. The stated price range was $11.855 to $12.15 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





58470H101

(CUSIP Number)
Jeffrey M. Rose
370 Lexington Avenue, Suite 1702,
NY, NY, 10017
323-232-0610

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
11/19/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Steamboat Capital Partners, LLC
Signature:/s/ Parsa Kiai
Name/Title:Parsa Kiai/Managing Member
Date:11/20/2026
Parsa Kiai
Signature:/s/ Parsa Kiai
Name/Title:Parsa Kiai
Date:11/20/2026
Comments accompanying signature:
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Keep reading